دانلود کتاب Pediatric Psychodermatology: A Clinical Manual of Child and Adolescent Psychocutaneous Disorders

فهرست مطالب :

Foreword I\nForeword II\nPreface\nAuthor index\nAbbreviations\nPart I: INTERFACE OF DERMATOLOGY AND PSYCHIATRY\n 1 Perspectives on management of pediatric dermatologie disorders\n 1.1 Introduction\n 1.2 Skin infections and infestations\n 1.2.1 Bacterial infections\n 1.2.2 Viral infections\n 1.3 HIV/AIDS\n 1.3.1 Non-infectious skin lesions\n 1.3.2 Bacterial infections in HIV\n 1.3.3 Viral infections in HIV\n 1.3.4 Fungal infections in HIV\n 1.3.5 Fungal infections\n 1.3.6 Topical antifungals\n 1.3.7 Infestations\n 1.4 Dermatitis\n 1.4.1 Irritant dermatitis\n 1.4.2 Dry-skin dermatitis\n 1.4.3 Seborrheic dermatitis\n 1.4.4 Allergic dermatitides\n 1.4.5 Idiopathic dermatitides\n 1.5 Hypersensitivity\n 1.5.1 Urticaria\n 1.5.2 Drug eruptions\n 1.6 Miscellaneous skin conditions\n 1.6.1 Acne vulgaris\n 1.6.2 Nevi\n 1.6.3 Papulosquamous disorders\n 1.6.4 Lichens\n 1.6.5 Psoriasis\n 1.7 Dermatologic manifestations of systematic disorders\n 1.7.1 Pruritus without rash\n 1.7.2 Inflammatory bowel disease (IBD)\n 1.7.3 Erythema nodosum\n 1.7.4 Pyoderma gangrenosum\n 1.7.5 Less common skin manifestations\n 1.7.6 Management\n 1.8 Collagen vascular disease\n 1.8.1 Lupus erythematosus (SLE)\n 1.8.2 Dermatomyositis\n 1.8.3 Juvenile idiopathic arthritis\n 1.8.4 Management\n 1.9 Endocrinologic disorders\n 1.9.1 Thyroid disorders\n 1.9.2 Diabetes mellitus\n 1.9.3 Adrenal disorders\n 1.9.4 Management\n 1.10 Hair and nails\n 1.10.1 Alopecia areata\n 1.10.2 Telogen effluvium\n 1.10.3 Androgenic alopecia\n 1.10.4 Trichotillomania\n 1.10.5 Traction alopecia\n 1.10.6 Hirsutism and hypertrichosis\n 1.10.7 Hair changes with systemic disease\n 1.10.8 Infection\n 1.10.9 Bacterial\n 1.10.10 Fungal\n 1.10.11 Onychodystrophy\n 1.10.12 Nail changes with systemic and nutritional disorders\n 2 Psychoneuroimmunology and other interactions between skin and psyche\n 2.1 Introduction\n 2.1.1 History of psychodermatology\n 2.1.2 Classification of psychodermatologic disorders\n 2.1.3 Psychological perspective of skin\n 2.1.4 Skin, mind, and the embryological embrace\n 2.2 Psychoneuroimmunology\n 2.2.1 Neuroendocrine response to stress\n 2.2.2 Immune response and central nervous system\n 2.2.3 Immune response and peripheral nervous system\n 2.2.4 Immune response and skin disease\n 2.2.5 Immune response and psychiatric disease\n 2.3 Conclusion\n 3 A clinician’s approach to psychocutaneous diseases in adolescents: Untying the Gordian knot\n 3.1 Introduction\n 3.1.1 History taking skills in adolescent patients\n 3.2 Interviewing the adolescent patient\n 3.2.1 Confidentiality\n 3.2.2 Parental confidentiality\n 3.2.3 Health questionnaires\n 3.2.4 Interview techniques\n 3.2.5 Active listening skills\n 3.3 Concepts of the physical examination\n 3.4 Successful management of the adolescent patient\n 3.4.1 Informed consent\n 3.4.2 Shared decision makings\n 3.4.3 Improving compliance\n 3.5 Conclusion\n 4 Quality of life issues in children and adolescents with dermatological conditions and their wider impact on the family and society\n 4.1 Introduction\n 4.2 Pediatric quality of life and its assessment\n 4.3 Skin disease and quality of life\n 4.3.1 Impact of skin diseases on children’s quality of life\n 4.3.2 Quality of life assessment in children with dermatological conditions\n 4.3.3 Children’s Dermatology Life Quality Index (CDLQI)\n 4.3.4 Infant’s Dermatitis Quality of Life Index (IDQoL)\n 4.3.5 Impact of skin disease on the quality of life of adolescents\n 4.4 Assessment of adolescents’ quality of life in dermatology\n 4.4.1 Teenager’s QoL questionnaire (T-QoL)\n 4.4.2 Skindex-Teen\n 4.4.3 Impact of skin disease on family quality of life: The “greater patient” concept\n 4.5 Assessment of family quality in dermatology\n 4.5.1 Family Dermatology Life Quality Index (FDLQI)\n 4.5.2 Dermatitis Family Impact questionnaire (DFI)\n 4.5.3 Parents’ Index of Quality of Life in Atopic Dermatitis (PIQoL-AD)\n 4.5.4 Childhood Atopic Dermatitis Impact Scale (CADIS)\n 4.5.5 Psoriasis Family Index (PFI)\n 4.6 Societal impact of childhood dermatological conditions\n 4.7 Conclusions\nPart II: PSYCHOPHYSIOLOGIC DISORDERS\n 5 Atopic dermatitis: a psychocutaneous review\n 5.1 Introduction\n 5.1.1 Epidemiology\n 5.2 Pathophysiologic factors in atopic dermatitis\n 5.2.1 Genetic predisposition\n 5.2.2 Socio-economic status\n 5.2.3 Family size\n 5.2.4 Food allergens\n 5.3 Psychoneuroimmunologic factors\n 5.3.1 Breast feeding\n 5.3.2 Environmental allergens\n 5.4 Psychophysiological aspects of atopic dermatitis\n 5.4.1 Impact of stress on the immunological system\n 5.4.2 Psychoanalytic hypothesis\n 5.4.3 Biopsychosocial model\n 5.4.4 Psychological dysregulation due to atopic dermatitis\n 5.5 Clinical features\n 5.6 Diagnosis\n 5.6.1 Allergy Testing\n 5.6.2 Differential Diagnosis\n 5.7 Management\n 5.7.1 Prevention of relapse\n 5.7.2 Food allergens\n 5.7.3 Aeroallergens\n 5.7.4 Optimizing the epidermal barrier (EB)\n 5.7.5 Hydration therapy\n 5.7.6 Management of pruritus\n 5.7.7 Topical corticosteroids\n 5.7.8 Topical immunomodulators\n 5.8 Systematic treatment of atopic dermatits\n 5.8.1 Antihistamines\n 5.8.2 Phototherapy\n 5.8.3 Antibiotics\n 5.8.4 Systemic corticosteroids\n 5.8.5 Immunomodulators\n 5.8.6 Cyclosporine\n 5.8.7 Azathioprine\n 5.8.8 Infliximab\n 5.8.9 Interferon-γ\n 5.8.10 Leukotriene inhibitors\n 5.9 Psychiatric comorbidities\n 5.9.1 Family dynamics\n 5.9.2 Internalizing and externalizing behaviors\n 5.9.3 Anxiety and depression\n 5.9.4 Personality traits\n 5.10 Management of psychiatric comorbidities\n 5.10.1 Multidisciplinary approach\n 5.10.2 Psychoeducation\n 5.10.3 Psychosocial assessment\n 5.10.4 Psychiatric symptoms review\n 5.10.5 Quality of life assessment\n 5.10.6 Psychodynamic therapy\n 5.10.7 Cognitive behavioral therapy\n 5.10.8 Behavioral modifications\n 5.10.9 Psychotropic medications\n 5.11 Conclusion\n 6 Psoriasis and children: A psychological approach\n 6.1 Introduction\n 6.1.1 Epidemiology\n 6.2 Dermatological clinical features\n 6.2.1 Plaque psoriasis\n 6.2.2 Guttate psoriasis\n 6.2.3 Erythrodermic psoriasis\n 6.2.4 Pustular psoriasis\n 6.2.5 Psoriatic arthritis\n 6.2.6 Inverse psoriasis\n 6.3 Psychological clinical features\n 6.3.1 Differential diagnosis\n 6.3.2 Psychotherapeutic intervention\n 6.3.3 Psychotherapy\n 6.4 Conclusions\n 7 The acnes: Acne vulgaris, acne rosacea, and acne excoriée\n 7.1 Acne Vulgaris\n 7.1.1 Introduction\n 7.1.2 Epidemiology\n 7.1.3 Pathogenesis\n 7.1.4 Classification\n 7.1.5 Management\n 7.1.6 Teratogenicity and isotretinoin\n 7.1.7 Depression, suicidality, and isotretinoin\n 7.2 Acne Rosacea\n 7.2.1 Pathophysiology\n 7.2.2 Management of acne rosacea\n 7.3 Acne Variants\n 7.4 Conclusion\n 8 Psychogenic purpura (Gardner-Diamond syndrome)\n 8.1 Introduction\n 8.2 History\n 8.3 Etiology and pathogenesis\n 8.4 Clinical features\n 8.5 Differential diagnosis\n 8.5.1 Disease course\n 8.5.2 Histopathology\n 8.5.3 Laboratory testings\n 8.5.4 Psychological disturbances\n 8.6 Treatment approaches and recommendations\n 8.7 Conclusion\nPart III: PSYCHIATRIC DISORDERS WITH DERMATOLOGIC MANIFESTATIONS\n 9 Body dysmorphic disorder in adolescents\n 9.1 Introduction\n 9.2 Definition\n 9.2.1 Epidemiology\n 9.2.2 Clinical features\n 9.2.3 Differential diagnosis\n 9.3 Management\n 9.3.1 Preliminary considerations\n 9.3.2 The clinical interview\n 9.3.3 Assessment\n 9.3.4 Patient education\n 9.3.5 Treatment\n 9.4 Other treatment techniques\n 9.4.1 Anxiety management training (AMT)\n 9.4.2 Eye movement desensitization and reprocessing (EMDR)\n 9.4.3 Family therapy\n 9.4.4 Group therapy\n 9.4.5 Metaphors\n 9.4.6 Mindfulness\n 9.4.7 Intervention\n 9.4.8 Nonpsychiatric medical treatment\n 9.4.9 Final management considerations\n 9.5 Conclusions\n 10 Delusional infestation in childhood, adolescence, and adulthood\n 10.1 Introduction\n 10.2 How to diagnose a delusion\n 10.3 Primary and secondary delusional infestation\n 10.4 The context of children and adolescence\n 10.5 Clinical pictures\n 10.5.1 Case one\n 10.5.2 Case two\n 10.5.3 Case Three\n 10.5.4 Commentary on these three cases\n 10.6 Delusional elaboration (“Wahnarbeit”)\n 10.7 Prevalence of delusional infestation\n 10.7.1 Treatment\n 10.7.2 Which antipsychotic in DI?\n 10.8 Antipsychotics\n 10.9 Conclusion\n 11 Dermatitis artefacta, skin picking, and other self-injurious behaviors: A psychological perspective\n 11.1 Introduction\n 11.2 Epidemiology\n 11.3 Etiology\n 11.4 Clinical features\n 11.4.1 Dermatitis Artefacta\n 11.4.2 Skin picking\n 11.4.3 Self-mutilation behavior\n 11.5 Differential diagnosis\n 11.6 Management\n 11.6.1 Pharmacological Treatment\n 11.6.2 Psychotherapy\n 11.6.3 Issues with Treatment\n 11.7 Conclusions\n 12 Trichotillomania\n 12.1 Introduction\n 12.2 Definition\n 12.3 Differential diagnosis\n 12.4 Assessment\n 12.5 Management\n 12.5.1 Psychotherapy\n 12.5.2 Medication\n 12.6 Conclusions: Future directions\n 13 Psychogenic pruritus with particular emphasis on children and adolescents\n 13.1 Introduction\n 13.2 Epidemiology\n 13.3 Clinical features\n 13.4 Differential diagnosis\n 13.5 Management\n 13.6 Conclusion\nPart IV: DERMATOLOGIC DISORDERS PREDISPOSING TO PSYCHIATRIC DISORDERS\n 14 Disorders of hair loss\n 14.1 Introduction\n 14.2 Causes of hair loss\n 14.3 Diagnostic approach to hair loss\n 14.3.1 History\n 14.3.2 Examination\n 14.3.3 Laboratory investigation\n 14.4 Tinea capitis\n 14.5 Telogen effluvium\n 14.6 Alopecia areata\n 14.7 Male pattern hair loss\n 14.8 Hair Loss due to Chemotherapy\n 14.9 Psychiatric aspects\n 14.9.1 Psychological treatment approaches\n 14.10 Conclusion\n 15 Disorders of skin pigmentation\n 15.1 Introduction\n 15.2 Disorders of hypopigmentation\n 15.2.1 Vitiligo\n 15.2.2 Albinism\n 15.2.3 Postinflammatory hypopigmentation\n 15.2.4 Pityriasis alba\n 15.2.5 Tinea versicolor\n 15.3 Disorders of hyperpigmentation\n 15.3.1 Postinflammatory hyperpigmentation\n 15.3.2 Melasma\n 15.3.3 Hyperpigmentation associated with medical disorders\n 15.3.4 Café-au-lait spots\n 15.3.5 Lentigines\n 15.4 Psychological aspects of disorders of pigmentations\n 15.4.1 Psychosocial management of disorders of pigmentation\n 15.5 Conclusion\n 16 Skin adnexal disorders\n 16.1 Hidradenitis suppurativa (HS)\n 16.1.1 Introduction\n 16.1.2 Diagnosis\n 16.1.3 Etiology\n 16.1.4 Clinical features\n 16.1.5 Differential Diagnosis\n 16.2 Hyperhidrosis\n 16.2.1 Definition\n 16.2.2 Epidemiology\n 16.2.3 Etiology\n 16.2.4 Clinical features\n 16.2.5 Differential diagnosis\n 16.2.6 Management\n 16.3 Anhidrotic ectodermal dysplasia\n 16.3.1 Definition\n 16.3.2 Epidemiology\n 16.3.3 Clinical features\n 16.3.4 Differential diagnosis\n 16.3.5 Management\n 16.4 Nevus sebaceous\n 16.4.1 Definition\n 16.4.2 Epidemiology\n 16.4.3 Clinical features\n 16.4.4 Differential diagnosis\n 16.4.5 Management\n 16.5 Conclusion\nPart V: SYSTEMATIC DISEASES WITH PSYCHODERMATOLOGIC MANIFESTATIONS\n 17 Neurocutaneous disorders\n 17.1 Introduction\n 17.2 Neurofibromatosis\n 17.2.1 Clinical features\n 17.2.2 Neuropsychiatric aspects of neurofibromatosis type 1\n 17.2.3 Management\n 17.2.4 NF1 summary\n 17.3 Tuberous Sclerosis Complex (TSC)\n 17.3.1 Introduction\n 17.3.2 Clinical features of TSC\n 17.3.3 Neurologic lesions\n 17.3.4 Psychiatric symptoms\n 17.3.5 Management\n 17.3.6 Treatment of neuropsychiatric problems\n 17.4 Conclusion\n 18 Collagen vascular disorders: Psychiatric and dermatologic manifestations\n 18.1 Lupus erythematosus (LE)\n 18.1.1 Epidemiology\n 18.1.2 Clinical features\n 18.1.3 Cutaneous manifestations\n 18.1.4 Neuropsychiatric systemic lupus erythematosus (NPSLE)\n 18.1.5 Differential diagnosis\n 18.1.6 Clinical diagnosis\n 18.1.7 Diagnostic workup\n 18.1.8 Management\n 18.1.9 Treatment of cutaneous lupus lesions\n 18.1.10 Treatment of NPSLE\n 18.2 Dermatomyositis\n 18.2.1 Epidemiology\n 18.2.2 Clinical features\n 18.2.3 Cutaneous manifestations\n 18.2.4 Psychiatric manifestations\n 18.2.5 Management\n 18.3 Rheumatoid Arthritis\n 18.3.1 Epidemiology\n 18.3.2 Etiopathogenesis\n 18.3.3 Clinical features\n 18.3.4 Cutaneous manifestations\n 18.3.5 Psychiatric manifestations\n 18.3.6 Laboratory findings\n 18.3.7 Management\n 18.3.8 Management of psychiatric issues\n 19 Psychocutaneous manifestations of endocrine disorders\n 19.1 Introduction\n 19.2 Diabetes Mellitus\n 19.2.1 Clinical features\n 19.2.2 Dermatological manifestations\n 19.2.3 Psychiatric manifestations\n 19.2.4 Management of psychiatric conditions\n 19.3 Disorders of growth hormone\n 19.3.1 Acromegaly\n 19.3.2 Dermatological manifestations\n 19.3.3 Psychiatric manifestations\n 19.3.4 Diagnostic workup\n 19.3.5 Clinical management\n 19.3.6 Management of dermatological manifestations\n 19.3.7 Management of psychiatric manifestations\n 19.4 Thyroid hormone disorders\n 19.4.1 Hypothyroidism\n 19.4.2 Hyperthyroidism\n 19.4.3 Clinical features of thyroid disorders\n 19.4.4 Dermatological manifestations of hypothyroidism\n 19.4.5 Dermatological manifestations of hyperthyroidism\n 19.4.6 Psychiatric manifestations\n 19.4.7 Diagnostic workup\n 19.4.8 Management of hypothyroidism\n 19.4.9 Management of hyperthyroidism\n 19.4.10 Management of psychiatric disorders\n 19.5 Adrenal gland disorders\n 19.5.1 Hypoadrenocorticism (adrenal insufficiency [AI] or Addison disease [AD])\n 19.5.2 Hyperadrenocorticism (Cushing syndrome)\n 19.6 Disorders of parathyroid glands\n 19.6.1 Hypoparathyroidism\n 19.6.2 Hyperparathyroidism\n 19.7 Disorders of hormones of the reproductive system\n 19.8 Androgen disorders\n 19.8.1 Hypogonadism in males\n 19.8.2 Androgen disorders in Females\n 19.9 Estrogen disorders\n 19.9.1 Estrogen disorders in males\n 19.9.2 Estrogen disorders in females\n 19.9.3 Psychiatric manifestations of disorders of androgen and estrogens\n 19.10 Conclusion\n 20 Inborn errors of metabolism with psychiatric and dermatologic features\n 20.1 Introduction\n 20.2 Phenylketonuria [PKU]\n 20.2.1 Genetics and pathophysiology\n 20.2.2 Clinical features\n 20.2.3 Cutaneous manifestations\n 20.2.4 Psychiatric manifestations\n 20.2.5 Laboratory diagnosis\n 20.2.6 Management\n 20.3 Hartnup disease\n 20.3.1 Genetics and pathophysiology\n 20.3.2 Cutaneous manifestations\n 20.3.3 Psychiatric manifestations\n 20.3.4 Laboratory findings\n 20.3.5 Management\n 20.4 Homocystinuria\n 20.4.1 Genetics and pathophysiology\n 20.4.2 Clinical features\n 20.4.3 Cutaneous manifestations\n 20.4.4 Psychiatric Manifestations\n 20.4.5 Management\n 20.5 Porphyrias\n 20.5.1 Genetics and prevalence\n 20.5.2 Clinical features\n 20.5.3 Cutaneous manifestations\n 20.5.4 Psychiatric manifestations\n 20.5.5 Laboratory diagnosis\n 20.5.6 Management\n 20.6 Conclusion\nPart VI: SPECIAL ISSUES IN MANAGEMENT OF PSYCHOCUTANEOUS DISORDERS\n 21 Psychiatric complications of dermatological treatments\n 21.1 Introduction\n 21.2 Epidemiology\n 21.3 Clinical features by medication category\n 21.3.1 Antibacterial agents\n 21.3.2 Antiviral agents\n 21.3.3 Corticosteroids\n 21.3.4 Dapsone\n 21.3.5 Antimalarial agents\n 21.3.6 Retinoids\n 21.3.7 Interferons\n 21.3.8 Other agents\n 21.4 Differential diagnosis\n 21.5 Management\n 21.5.1 Drug-drug interactions\n 21.5.2 Non-pharmacologic interventions\n 21.6 Conclusion\n 22 Dermatologic manifestations of psychotropic medications\n 22.1 Introduction\n 22.1.1 Epidemiology\n 22.2 Diagnosis\n 22.3 Pathogenesis\n 22.4 Categories\n 22.5 Common adverse cutaneous reactions\n 22.5.1 Pruritus\n 22.5.2 Exanthematous eruptions\n 22.5.3 Urticaria and angioedema\n 22.5.4 Fixed drug eruptions\n 22.5.5 Photosensitivity\n 22.5.6 Pigmentation\n 22.5.7 Diaphoresis\n 22.5.8 Alopecia\n 22.6 Serious and life-threatening cutaneous reactions\n 22.6.1 Erythema multiforme\n 22.6.2 Stevens-Johnson Syndrome and Toxic Epidermolysis Necrolysis\n 22.6.3 Drug hypersensitivity syndrome\n 22.6.4 Vasculitis\n 22.6.5 Exfoliative dermatitis\n 22.6.6 Anaphylactoid reactions\n 22.7 General dermatologic conditions\n 22.7.1 Acneiform eruptions\n 22.7.2 Psoriasiform eruption\n 22.7.3 Seborrheic eruption\n 22.7.4 Lichenoid eruption\n 22.8 Conclusion\n 23 Non-pharmacological approaches to treat psychocutaneous disorders\n 23.1 Introduction\n 23.2 Non-pharmacological modalities\n 23.2.1 Acupuncture\n 23.2.2 Aromatherapy\n 23.2.3 Biofeedback\n 23.2.4 Brief dynamic psychotherapy\n 23.2.5 Cognitive behavioral therapy methods\n 23.2.6 Emotional freedom techniques (EFT)\n 23.2.7 Eye Movement Desensitizing and Reprocessing (EMDR)\n 23.2.8 Hypnosis\n 23.2.9 Music\n 23.2.10 Placebo\n 23.2.11 Suggestion\n 23.3 Conclusion\n 24 Psychiatric disorders frequently encountered in dermatology practices\n 24.1 Introduction\n 24.1.1 Epidemiology\n 24.2 Mood disorders\n 24.2.1 Epidemiology\n 24.2.2 Diagnosis of depressive disorders\n 24.2.3 Differential diagnosis of depressive disorders\n 24.2.4 Management of depressive disorders\n 24.3 Bipolar spectrum disorders\n 24.3.1 Types of bipolar disorders\n 24.3.2 Diagnosis of bipolar disorders\n 24.3.3 Differential diagnosis of bipolar disorders\n 24.4 Anxiety spectrum disorders\n 24.4.1 Obsessive compulsive disorder\n 24.4.2 Social anxiety disorder (SAD)\n 24.4.3 Eating disorders\n 24.5 Personality disorders (PDs)\n 24.5.1 Introduction\n 24.5.2 Clinical diagnosis\n 24.6 Conclusion\nAPPENDIX\n 25 About the editors\n 26 FDA approved psychotropic medication indications for children and adolescents\n 27 Common psychiatric terms\n 28 Common dermatotologic lesions\nIndex\nPlate section